These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33618069)

  • 1. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma.
    Fan C; Hu H; Shen Y; Wang Q; Mao Y; Ye B; Xiang M
    Transl Oncol; 2021 Apr; 14(4):101042. PubMed ID: 33618069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration.
    Chen Q; Chen J; Lu Z; Nian R; Li W; Yao Z; Mou S; Liu Y; Cao X; He W; Zhu C
    Discov Oncol; 2024 Mar; 15(1):57. PubMed ID: 38430385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
    Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK6 inhibits lymphoid cell infiltration and represents a prognostic marker in HPV+ squamous cell carcinoma of head and neck.
    Tang C; Lin L; Zhou W; Liu X; Fu Y; Zhang L; Li L; Wang X; Zhao L; Liang J
    Chin J Cancer Res; 2019 Dec; 31(6):901-909. PubMed ID: 31949392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang S; Yu S; Wang J; Cheng Z
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Zhang Y; Li L; Zheng W; Zhang L; Yao N
    Ann Transl Med; 2022 Mar; 10(6):273. PubMed ID: 35434003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.
    Zhong R; Yang M; Zhu R; Zhang J; Wang L
    Oncol Lett; 2023 Apr; 25(4):133. PubMed ID: 36909370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma.
    Sankar D; Kannan B; Jayaseelan VP; Manicka Vasagam J; Arumugam P
    J Oral Biol Craniofac Res; 2024; 14(1):1-7. PubMed ID: 38075236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the Immune-Related Genes in Tumor Microenvironment That Associated With the Recurrence of Head and Neck Squamous Cell Carcinoma.
    Chengcheng L; Wenwen Q; Ningyue G; Fangyuan Z; Runtong X; Zhenxiao T; Fenglei X; Yiming Q; Miaoqing Z; Xiaoming L; Ming X
    Front Cell Dev Biol; 2021; 9():723721. PubMed ID: 34490269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma.
    Li Y; Zheng JN; Wang EH; Gong CJ; Lan KF; Ding X
    PeerJ; 2020; 8():e10385. PubMed ID: 33304653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma.
    Mao L; Pan Z; Chen W; Hu W; Chen X; Dai H
    BMC Med Genomics; 2023 Mar; 16(1):67. PubMed ID: 36998036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCDC71L as a novel prognostic marker and immunotherapy target via lipid metabolism in head and neck squamous cell carcinoma.
    Zhang Y; Tang H; Zi M; Zhang Z; Gao Q; Tian S
    J Stomatol Oral Maxillofac Surg; 2024 Dec; 125(6):101799. PubMed ID: 38367702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma.
    Xu L; Jin Y; Qin X
    Int Immunopharmacol; 2020 Oct; 87():106844. PubMed ID: 32738592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma.
    Li B
    Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma.
    Avs KR; Pandi C; Kannan B; Pandi A; Jayaseelan VP; Arumugam P
    Clin Oral Investig; 2023 Nov; 27(11):6961-6969. PubMed ID: 37861747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.